Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Jaundice, a common occurrence in newborns, manifests as a yellow discoloration of the skin and eyes due to elevated levels of bilirubin in the bloodstream, a condition known as hyperbilirubinemia. American Family Physician (AFP) reports that approximately 50% of full-term and 80% of preterm infants experience jaundice within the first week of life. It stands as the most prevalent condition necessitating medical attention in newborns and is a leading cause for hospital readmission following early discharge.
The prevalence of neonatal jaundice in infants has led to an increased demand for bilirubin blood test devices and consumables, essential for the accurate diagnosis and treatment of newborns.
Jaundice in newborns can stem from various factors, including physiologic jaundice, breast milk jaundice, and jaundice resulting from hemolysis. Physiologic jaundice, a common occurrence, is typically a transient and benign condition resulting from the immature liver's inability to efficiently process bilirubin. Breast milk jaundice, on the other hand, is a prolonged form of jaundice associated with breastfeeding and is not typically harmful. Jaundice arising from hemolysis, where red blood cells break down excessively, can lead to an increased production of bilirubin.
The importance of timely and accurate diagnosis of neonatal jaundice cannot be overstated, considering its widespread occurrence and potential complications. The bilirubin blood test serves as a crucial diagnostic tool, allowing healthcare professionals to assess bilirubin levels in a newborn's blood and determine the appropriate course of action.
Given the high incidence of jaundice in both full-term and preterm infants, medical professionals often encounter cases that require intervention. The severity and duration of jaundice can vary, necessitating careful monitoring and, in some cases, treatment to prevent complications. In instances where bilirubin levels are significantly elevated, interventions such as phototherapy or, in severe cases, exchange transfusion may be recommended.
The demand for bilirubin blood test devices and consumables has witnessed a notable surge due to the critical role they play in the management of neonatal jaundice. These devices enable quick and accurate assessments of bilirubin levels, facilitating timely interventions and ensuring the well-being of newborns.
Neonatal jaundice is a prevalent condition affecting a significant percentage of newborns, emphasizing the need for effective diagnostic tools and interventions. The bilirubin blood test devices and consumables have become indispensable in the medical arsenal, enabling healthcare professionals to diagnose and manage jaundice in newborns efficiently. As advancements in medical technology continue, these tools are likely to evolve, contributing to enhanced care and outcomes for infants affected by jaundice.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Developing Countries Can Become Potential Market For Advanced Bilirubin Blood Test Devices |
Bilirubin Blood Test Market Highlights:
Bilirubin Blood Test Market Overview
Bilirubin Blood Test Market Size was valued at USD 1.17 Billion in 2023. The Global Bilirubin Blood Test industry is projected to grow from USD 1.26 Billion in 2024 to USD 2.25 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.63% during the forecast period (2024 - 2032).
A yellowish-orange substance present in the human blood is called bilirubin. This natural coloring is secreted by our liver. It is discharged in bile and is formed from the breaking down of hemoglobin. From the blood, it reaches the liver and gets stored there. Bilirubin gets removed from the body through excretory passages. The condition of high bilirubin level is common in infants. It results in the yellowing of skin and eyes. A bilirubin blood test is conducted to check the level of yellow bilirubin in the blood. When the liver is functioning properly, it expels all the bilirubin from the body. In case the level of bilirubin is high, it gets drained from the liver and causes diseases such as jaundice, dark urine, and others. A high bilirubin blood test enables us to monitor the count of bilirubin in the blood, therefore, detects the problems related to gallbladders.
Covid19 Analysis
Due to the spread of infectious coronavirus, people are facing several respiratory problems. Many patients have reported high blood test bilirubin levels, which is a serious concern. Although the death rate because of rising in bilirubin level is not high.
The government and medical agencies are investing in Research & Development programs. It will make rapid diagnosis easy. Low bilirubin blood test and high bilirubin blood test include a cumbersome process of sample collection, fluid handling, device packaging, etc. Therefore, a need arises to develop more effective ways of conducting the bilirubin blood test with the least spoilage.
Market Dynamics
Drivers
The diseases such as jaundice, dark urine, and problems related to the gallbladder, are increasing rapidly. It is leading to the rise in demand for bilirubin blood testing apparatus. New-born children or infants are more prone to such problems because their liver is not absorbing bilirubin properly immediately after their birth. This has boosted the market demand for portable and easy-to-use testing kits. Thus, the bilirubin blood test market size is expected to grow rapidly throughout the forecasted period.
Opportunities
Bilirubin blood test market growth can be attributed to the constant technological changes. The need for developing new apparatus and techniques of testing is increasing so that more accurate and trustworthy results can be drawn. The transferable and easy-to-use testing kits are being developed for this purpose. People are becoming aware and are adapting to a healthy lifestyle. The government of every nation is also investing its resources in healthcare camps where a large number of people are treated. This has amplified the bilirubin blood testing percentage.
Restraints
Some other sorts of testing techniques that are being used by people or agencies other than the pathological labs or research institutes are proposing a real threat to bilirubin blood testing market size. The test conducted by non-pathological personnel is not trustworthy and can show false results.
Value Chain Analysis
The key players in the field of the bilirubin blood test market are making technological advancements. They are launching such instruments which will require a minimum ounce of blood for testing the level of bilirubin in the blood of a patient. As the cases of jaundice are more in infants and newborns, the companies are developing techniques that will be less painful and will cause no harm to them.
Market Segmentation
Bilirubin blood test market can be divided into various segments. These are: based on test type, based on product type, based on application, and based on end-users.
Based on test type
Various kinds of tests conducted in bilirubin blood test market are as follows: Total Serum Bilirubin (TSB); Direct/Conjugated Bilirubin Test; Indirect/Unconjugated Bilirubin Test
Based on product type
Based on product type, the bilirubin blood test market is divided into two types, namely, consumables and instruments. Consumables are not reusable materials. Consumables alone accounted for a market stake of 47.37% in the year 2015, which was the highest among all other segments. The instruments can further be classified into analyzers and bilirubin meters.
Based on application
The market is divided into infants or newborn children and adults. The chances of jaundice in pediatrics are more than that of adults, therefore, infants form the largest percentage of the consumers of the bilirubin blood test market.
Based on end-users
Bilirubin blood testing is done at diagnostics centers, pathological labs, and hospitals. Research laboratories and other academic institutions also contribute a large share to the market. Pediatric clinics and child specialist hospitals are also end-user.
Regional Analysis
Bilirubin blood test market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include North America, Europe, Asia-pacific, and the rest of the world.
North America, which includes the area of the US and Canada, is overshadowing all the other regions. It accounted for a share of 39.10% in the year 2014, which was the largest in the global bilirubin blood test market. The market share of the US alone is anticipated to reach a CAGR of 4.93%.
The European region, which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the bilirubin blood test market. It is presumed that Germany will touch the largest value, accounting for USD 158.6 million, by the end of the year 2027.
Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for bilirubin blood testing. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. The market of these regions will grow with a CAGR of 6.45%. China alone had a market share of 34.10% in the year 2015.
The rest of the world, which includes regions of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.
Competitive Landscape
The list of major key players involved in the global bilirubin blood test market analysis is as follows:
- Koninklijke Philips N.V. (Noord-Holland)
- Beckman Coulter, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Randox Laboratories Ltd. (UK)
- Hoffmann-La Roche AG (Switzerland)
- Drägerwerk AG & Co. KGaA (Germany)
- Ginevri (Italy)
- Advanced Instruments (US)
- Reichert, Inc. (US)
- Instrumentation Laboratory (US).
- AVI Healthcare Pvt. Ltd.
The above-listed companies work on the testing and origination of new equipment and techniques in the field of bilirubin blood testing. They come together in joint ventures, mergers, and, acquisitions, launching new devices. Their main objective is to deliver devices that are cost-effective, hassle-free in operations, and give concrete results.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
